© 1995 American Heart Association, Inc.
Articles |
Dominant Social Status and Contraceptive Hormone Treatment Inhibit Atherogenesis in Premenopausal Monkeys
From the Comparative Medicine Clinical Research Center (J.R.K., M.R.A., M.S.A., T.B.C.) and the Department of Public Health Sciences (T.M.M.), Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC, and the Behavioral Physiology Laboratory, University of Pittsburgh, Pa (S.B.M.).
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract The stress of social subordination is associated with exacerbation of coronary artery atherosclerosis in premenopausal cynomolgus monkeys, possibly as a result of the ovarian dysfunction that reliably accompanies subordinate social status. The primary objective of the current study was to determine whether treatment with an oral contraceptive (OC) provides relative protection from development of atherosclerotic plaques, especially among animals made vulnerable to atherosclerosis by social subordination. In the present study, 193 adult female monkeys (Macaca fascicularis) were placed in social groups of 5 or 6 animals each. Half of the animals were then fed an atherogenic diet to which had been added a triphasic OC, while the remainder received only the atherogenic diet. At the end of 26 months, atherosclerosis was measured in an iliac artery biopsy taken from each monkey. The results demonstrated that among untreated animals subordinate individuals developed significantly more atherosclerosis than did their dominant counterparts (P<.01); however, OC treatment inhibited atherosclerosis in subordinate animals (P<.05) and eliminated the difference between dominant and subordinate animals that was observed in the untreated condition. Subordinate social status and OC treatment were both associated with reduced plasma concentrations of HDL cholesterol (P<.01 for both), and subordinate monkeys also had elevations in LDL cholesterol plus VLDL cholesterol (P<.01). Nonetheless, the interaction between social status and OC treatment remained significant even after covariance adjustment for variation in plasma lipids. Taken together, these results suggest that social subordination worsens, whereas OC treatment inhibits, atherosclerosis, and that these effects are independent of concomitant variability in plasma lipids.
Key Words: cynomolgus monkeys • atherosclerosis • stress • oral contraceptives • risk factors
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Considerable evidence supports the hypothesis that ovarian hormones suppress the development of atherosclerosis and CHD in women. For example, surgical or natural menopause is associated with an increased incidence of CHD, an outcome that can be reduced significantly by hormone replacement therapy.1 2 Similarly, investigations using nonhuman primates have shown that ovariectomy (surgical menopause) exacerbates coronary artery atherosclerosis, whereas parenteral estrogen replacement, with or without progesterone, inhibits it.3 4 If ovarian hormones are indeed cardioprotective, then sustained or extreme interruptions of normal ovarian function, which may occur in up to 18% of women less than 40 years old,5 6 7 8 could also place affected premenopausal individuals at risk for developing premature atherosclerosis and CHD. For example, one study links a lifelong history of menstrual irregularity in women to an increased incidence of acute myocardial infarction.9 Furthermore, investigations with premenopausal monkeys have established that the stress associated with chronically low social status (subordination to dominant animals within social groups) is associated with an increased frequency of anovulatory and luteal phase–deficient menstrual cycles10 11 and with exacerbation of coronary artery atherosclerosis.12 13 The current study was an intervention trial designed to explore the potential public health implications of the foregoing association among psychosocial stress, ovarian hormones, and atherosclerosis. The three major objectives of this investigation were to (1) confirm that low social status enhances the vulnerability of female monkeys to atherosclerosis; (2) evaluate the hypothesis that contraceptive hormone treatment provides relative protection from development of atherosclerosis, especially in those animals at increased risk of ovarian impairment by subordinate social status; and (3) determine the effects on plasma lipids of a contraceptive regimen containing low doses of ethinyl estradiol and levonorgestrel and to establish whether any such effects influenced atherogenesis.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Animals
The study animals were 213 female cynomolgus monkeys (Macaca fascicularis) imported from Indonesia as fully mature, premenopausal adults (average age, 5.7 years, estimated from dentition). Premenopausal females of this species are susceptible to diet-induced atherosclerosis and have previously proven useful in studies of behavioral and hormonal influences on coronary artery atherosclerosis.14
Experimental Design and Procedures
All animals were housed in single cages for 6 weeks of a 3-month
quarantine period and then placed in social groups of 5 or 6 animals
each, with all groups housed in pens measuring approximately 2x3x3
m3 with outdoor exposure. The monkeys were fed a commercial
chow diet (Purina 5045, Ralston Purina) throughout the quarantine and
pre-experimental periods. The animals were assigned by social group
to either an OC or control condition. A blocked randomization procedure
with two groups per block was used to ensure equivalence in the
numbers, characteristics, and experimental timing of animals assigned
to the two conditions. Experimenters as well as study technicians were
blinded to the treatment assignments. After their entry into the
experiment, the monkeys consumed a moderately atherogenic diet
containing 43% of calories from fat and 0.28 mg
cholesterol/kcal (127 mg cholesterol/100 g dry
weight constituents) (Table 1
). Animals were fed twice
daily (at 7 AM and 2 PM) and received an amount
of food sufficient to provide 120 kcal·kg body
wt-1·d-1. The duration of this part of
the experiment was 26 months, at the end of which time a biopsy sample
was removed from the right iliac artery of each monkey for
determination of atherosclerosis.
Atherosclerosis measured in this sample was used as the
primary dependent measure in the current investigation. All monkeys
exposed to the biopsy procedure also underwent bilateral oophorectomy.
These animals were then assigned to a second experiment designed to
evaluate the effects of postmenopausal treatments on coronary
artery atherosclerosis.
|
There were 213 animals in the study when it began; data from 193
monkeys are reported here. Twenty monkeys died,
representing a mortality rate of 3.7% per annum of
experimental exposure. Notably, 16 of the deaths (generally of monkeys
that had low body weight and enteric disorders) occurred among animals
treated with an OC, and the remaining 4 were in monkeys from the
control group (
2=5.91, P<.02). There
is no ready explanation for the disparate number of deaths in the two
groups.
All procedures involving animals were conducted in compliance with state and federal laws, standards of the US Department of Health and Human Services, and guidelines established by our Institutional Animal Care and Use Committee. For routine sample collection, animals were anesthetized with ketamine hydrochloride (15 mg/kg) administered intramuscularly. Ketamine hydrochloride (15 mg/kg) and butorphanol (0.025 mg/kg) were used for surgical anesthesia when ovariectomies were done.
Pharmacological Manipulation
The OC chosen for use in this experiment contained a combination
of ethinyl estradiol and levonorgestrel (Triphasil,
Wyeth-Ayerst). The drug was finely ground and administered in the diet
on a 28-day cycle. Different proportions of estrogen and progestin were
provided for the initial 21 days of each cycle, and a placebo was given
for the final 7 days (Table 2). As shown in Table 2, the
OC was included in the diet on a caloric rather than a body weight
basis. This was done because of the relatively high
metabolic rate of cynomolgus monkeys. Females of this
species have a caloric intake nearly one fifth that of human females
despite weighing only one twentieth as much. The drug was administered
throughout the 26-month period of the experiment. To determine the
effectiveness of hormone delivery, plasma ethinyl estradiol and
levonorgestrel were sampled 10 times over the course of the
study, on day 21 of the pill cycle. These samples revealed that blood
concentrations averaged 60.7 pg/mL ethinyl estradiol and 1.27 ng/mL
levonorgestrel, comparable to those observed in women using
the same compound. Animals in the untreated group received only the
atherogenic diet, were fed at the same time of day, and lived in
adjacent pens.
|
Determination of Social Status
We have reported previously that the stress of social
subordination among premenopausal monkeys fed an atherogenic diet
results in ovarian dysfunction, estrogen deficiency, a reduced
ratio of TPC to HDLC, and exacerbated coronary artery
atherosclerosis.10 11 12 13 14 For cynomolgus
monkeys, a series of specific facial expressions, postures, and
vocalizations indicate the occurrence of a fight, and an animal's
relative social status may be based on these. Typically, one animal in
a fight signals aggression and the other signals submission,
particularly in stable social groupings.15 This highly
asymmetric pattern allows fight outcomes to be judged in terms of clear
winners and losers.16 17 The female in each group that
defeats all others (as evidenced by her ability to elicit
consistently submissive responses) is designated as the
first-ranking monkey. The female that defeats all but the
first-ranking monkey is designated as the second-ranking
monkey, and so forth. In general, dominance relationships within small
groups are transitive; that is, if monkey 1 is dominant to monkey 2 and
monkey 2 is dominant to monkey 3, then monkey 1 is usually dominant to
monkey 3 also.13 Dominance was determined weekly for all
groups on the basis of data collected by technicians who recorded
all fights observed during a 30-minute period. Social status was stable
during both the experimental and pre-experimental periods of the
present study. The average correlation between ranks measured in
consecutive months was greater than .90, whereas ranks aggregated over
the entire experimental period correlated with those determined
pre-experimentally at r=.96. The aggregated experimental
period rankings were used in all analyses, with animals above
the median considered dominant and those below the median subordinate.
That is, overall median rank was used as the cutpoint for determining
dominant versus subordinate status.
Clinical Evaluations
During the pretreatment and treatment periods, several
determinations of plasma lipids and body weight were made. All sample
collections were made after an 18-hour fast while the animals were
anesthetized. TPC and plasma HDLC concentrations were
determined once pre-experimentally and nine times during the study
by use of previously published methods.18 19 LDLC and
VLDLC were calculated together as the difference between TPC and HDLC.
Blood pressure was measured indirectly with a Dinamap portable
adult/pediatric and neonatal vital signs monitor (model 8100), which
uses an oscillometric technique. Measurements were taken once before
the experiment and three times during the study. Previous work at our
center has shown that indirect measurements of blood pressure
recorded in animals under ketamine anesthesia
correlate well with blood pressure measurements obtained from the same
animals when they are fully conscious.20 Animals were
weighed every other month during both the pre-experimental and
experimental phases of the study. Finally, blood samples collected from
a small subset of untreated animals (n=22) three times per week for 10
weeks were evaluated for plasma progesterone
concentrations.10 The peak progesterone concentrations
from the luteal phase of each cycle were identified; these peaks were
averaged to provide a mean progesterone value for each monkey. The data
then were assessed with respect to the dominance status of the animals.
All hormone assays were done at Dr Mark Wilson's Comparative
Endocrinology Laboratory of the Yerkes Regional Primate Center
(Atlanta, Ga).
Iliac Artery as a `Surrogate' for the Coronary
Artery
The study animals were not necropsied at the termination of the
current experiment to allow their use in a subsequent trial
investigating postmenopausal as well as premenopausal influences on
atherosclerosis. Because biopsy of the coronary
arteries was not feasible, an alternative artery was chosen to provide
information on the atherogenicity of the premenopausal treatments.
Ideally, such an artery would react to an atherogenic stimulus in a
manner similar to that of the coronary arteries. We have termed
these alternative arteries "surrogate" or indicator arteries. We
considered the common carotid and iliac arteries for this purpose,
because removal of either does not affect tissue perfusion distally. A
series of comparisons in which data from 116 reproductively
intact and ovariectomized female monkeys were used revealed that the
average correlation between atherosclerosis extent in
the common iliac artery and the coronary arteries (mean extent
in left circumflex, left anterior descending, and right arteries) was
.71. In the same sample, the average correlation between
atherosclerosis in the common carotid and
coronary arteries was .60. On the basis of these data, we
concluded that the common iliac artery was a reasonable surrogate
artery for the determination of atherosclerosis.
Determination of Atherosclerosis
To obtain biopsy material, we first anesthetized the
animals with ketamine and butorphanol as described above. Then
a longitudinal incision was made, the viscera were retracted to expose
the aorta, and a 3-cm section of the left common iliac artery was
removed after ligation distally and proximally. The section was
perfusion fixed with 10% neutral buffered formalin at a pressure of
100 mm Hg for 10 minutes. The iliac artery section was then placed in a
vial of 10% neutral buffered formalin with a suture indicating the
distal end. To evaluate the extent of iliac
atherosclerosis, we cut five standard blocks (each
approximately 3 mm in length) perpendicularly to the long axis of the
artery. The tissue blocks were dehydrated by increasing concentrations
of ethanol and embedded in paraffin. Two 5-µm sections were cut from
each block, and one was stained with Verhoeff–van Gieson's stain
and the other with hematoxylin and eosin. We determined intimal area
from the Verhoeff–van Gieson–stained sections by digitizing
the area between the internal elastic lamina and the luminal surface of
the artery. The mean of the five sections was used to represent
each animal.
Statistical Analysis
To reduce skewness and equalize group variances, all
atherosclerosis data underwent square root
transformation of the form X'= 214 
before
analysis.21 ANOVA and ANCOVA were used for
initial statistical analysis. Where appropriate, a priori
comparisons by t tests22 were used to test the
significance of hypothesized group contrasts.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Iliac Artery Atherosclerosis
An approximately equivalent number of animals could be categorized as either dominant or subordinate in each experimental condition. The mean intimal areas of dominant and subordinate animals in the treated and untreated conditions are depicted in Fig 1
. Actual
values, standard errors, and the numbers of animals in each condition
are included in Table 3. For determination of whether OC
treatment or social status influenced extent of iliac artery
atherosclerosis, the intimal area measurements were
subjected to a 2x2 (experimental
conditionuntreated,treatedxstatussubordinate,dominant)
ANOVA. The ANOVA showed a main effect for status
(F1,189=5.57, P<.02), as well as a
statusxcondition interaction (F1,189=6.18,
P=.01). Because of these effects, t tests were
used for evaluation of preselected orthogonal contrasts between groups.
The particular contrasts chosen reflected three predictions: (1)
untreated dominant monkeys would be protected compared with
subordinates; (2) OC-treated subordinates would be protected compared
with subordinate monkeys in the untreated condition; and (3)
atherosclerosis in OC-treated dominants and
subordinates would not differ. These predictions were all
substantiated. The first contrast revealed that untreated dominant
monkeys had significantly less atherosclerosis than did
their untreated subordinate counterparts (P<.01). The
second comparison demonstrated that treated subordinates had
significantly less atherosclerosis than did untreated
subordinate monkeys (P<.05). The third comparison
demonstrated that there was no difference in
atherosclerosis between dominant and subordinate
animals in the treated condition (P=NS).
|
|
For illustrative purposes, we plotted the mean
atherosclerosis score (in mm2) for animals
grouped on the basis of average rank into one of five categories, from
high to low (Fig 2). This figure demonstrates that the
relationship we have already reported for dominant and subordinate
animals in the control condition appears to be linear across the range
of social status. In contrast, there is no apparent association between
social rank and atherosclerosis among OC-treated
animals.
|
Clinical Observations
Parallel to the atherosclerosis data, the plasma
lipid determinations obtained during the experiment were subjected to a
series of 2x2
(conditionuntreated,treatedxstatussubordinate,dominant)
ANOVAs. The relevant data are shown in Table 4. The
analysis for HDLC revealed main effects for both condition
(F1,189=30.62, P<.01) and status
(F1,189=5.61, P<.02), indicating that HDLC was
suppressed in treated compared with untreated animals and in
subordinates compared with dominants. The conditionxstatus interaction
approached significance (F1,189=3.44, P<.07).
There was a significant status effect for LDLC+VLDLC
(F1,189=8.95, P<.01), indicating that
LDLC+VLDLC was lower, overall, in dominant monkeys than in subordinate
monkeys. Neither the condition effect nor the conditionxstatus
interaction was significant for LDLC+VLDLC. Across all animals, both
HDLC and LDLC+VLDLC were significantly associated with
atherosclerosis extent (r=-.39 for
HDLC and r=.51 for LDLC+VLDLC, P<.01 for both)
as well as within treatment groups (treated, r=-.40
for HDLC and r=.51 for LDLC+VLDLC; untreated,
r=-.47 for HDLC and r=.53 for LDLC+VLDLC;
P<.01 for all).
|
These data indicate that both OC treatment and status influenced
the major lipid risk factors for atherosclerosis and
that these factors were themselves associated significantly with
atherosclerosis extent. Because the effects of OC
treatment and status on atherosclerosis may have been
mediated, in part, by plasma lipids, the
atherosclerosis data were subjected to a 2x2
(conditionuntreated,treatedxstatussubordinate,dominant)
ANCOVA, with HDLC and LDLC+VLDLC entered as covariates. This
analysis yielded a significant condition effect
(F1,187=4.24, P<.05) as well as the previously
observed conditionxstatus interaction
(F1,187=4.25, P<.05) (Fig 2
). The
latter outcome suggests that the interactive influence of social status
and OC treatment on atherosclerosis could not be
accounted for by concomitant variability in serum lipid concentrations
among these experimental animals. The significant condition effect
indicated that OC treatment is generally protective, but only after
adjustment for the potential adverse effects of such treatment on
plasma lipids (Fig 3).
|
Systolic and diastolic blood pressures were
measured before and during the experiment (Table 5).
Conditionuntreated,treatedxstatussubordinate,dominant
ANOVAs indicated that pretreatment systolic and
diastolic blood pressure measurements were higher among
dominant animals than among their subordinate counterparts
(systolic, F1,189=10.38, P<.01;
diastolic, F1,189=9.75, P<.01).
There were no significant differences pre-experimentally by
condition, nor was there a significant conditionxstatus
interaction. Accordingly, systolic and diastolic
values obtained during the experiment were subjected to
conditionuntreated,treatedxstatussubordinate,dominant
ANCOVAs, with the pre-experimental values used as covariates.
Adjustment for pre-experimental values completely eliminated all
significant effects (adjusted values in Table 5). Notably, none of
these blood pressure measurements were correlated significantly with
atherosclerosis (r<.10 for all,
P=NS).
|
Body weight was also measured before and during the experiment. A conditionuntreated,treatedxstatussubordinate,dominant ANCOVA, with the pre-experimental values used as covariates, was applied to these data. This analysis revealed that no significant effects of either OC treatment or status were manifested during the experiment (control subordinate, 2.99±0.03 kg; control dominant, 3.00±0.02 kg; treated subordinate, 3.06±0.03 kg; treated dominant, 3.01±0.03 kg [mean±SEM]). However, a subsidiary analysis comparing pre-experimental and experimental body weights across groups indicated that animals, in general, gained weight (pre-experimental, 2.98±0.03 kg; experimental, 3.02±0.03 kg; P<.05).
Finally, peak luteal phase plasma progesterone concentrations were assessed in a subset of 22 animals from the untreated group. These data confirmed that, as in previous investigations, there was a significant inverse relationship in this experiment between ovarian function and social status. Specifically, mean peak progesterone concentrations averaged 10.36±1.28 ng/mL in 11 dominant monkeys and 6.05±1.46 ng/mL in 11 subordinate monkeys (t21=2.22, P<.04).
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Female cynomolgus macaques fed atherogenic diets have been shown to be suitable models for the development of coronary artery atherosclerosis in terms of male/female differences, reproductive hormone influences, and behavioral effects.3 4 The present study extends earlier results by demonstrating that social factors and OC treatment interact to influence atherogenesis in premenopausal animals. Specifically, the stress of low social status was associated with worsened atherosclerosis among untreated monkeys; however, treatment with an OC inhibited the development of atherosclerosis in subordinate animals and eliminated these differences between dominant and subordinate monkeys. Thus, equivalent protection from atherosclerosis was observed among untreated dominant females and all treated animals. Notably, atherosclerotic plaque development was inhibited in treated monkeys despite the profound reduction in HDLC that accompanied OC treatment. To the extent that these results represent concomitant events in women, they highlight the potential importance of behavioral stressors in the development of atherosclerosis during the premenopausal period. They also illuminate the possible antiatherogenic effects of OC treatment among premenopausal women with estrogen deficiency.
Premenopausal women usually are considered relatively protected from atherosclerosis and CHD.23 However, this protection diminishes after menopause, as the incidence of CHD in women ultimately becomes equivalent to that observed in men.24 The exacerbation of atherosclerosis observed in the present study among untreated, socially subordinate monkeys suggests that there also may be a subset of premenopausal women who, perhaps because of behavioral factors, experience an accelerated development of atherosclerosis. The existence of such a subset would help explain the occurrence of CHD among some premenopausal women, as well as the apparently rapid onset of CHD during the postmenopausal period. Consistent with this suggestion are the results of numerous studies in women relating an increase in CHD risk to low-status occupations (eg, clerical workers and video-display terminal operators) and an inability to express or discuss anger.25 The behavioral situation of such women may be characterized as a form of stress involving low control, high demands, and suppressed emotions.25 Significantly, low social status in confined monkeys also is often considered stressful to the animals, in part because it is accompanied by relative social withdrawal and isolation and a generally reduced freedom of movement and expression.13 26 27
The mechanism or mechanisms mediating an association between social stress and increased risk of CHD (in women) or atherosclerosis (in premenopausal monkeys) remain unknown. However, in previous investigations that focused on menstrual cyclicity in cynomolgus monkeys, we have observed that subordinate social status is reliably associated with a significant increase in anovulatory and luteal phase–deficient menstrual cycles.10 11 In addition, other investigators have noted reduced reproductive performance in subordinate monkeys.28 29 30 31 32 In the present study, data from a subset of untreated monkeys indicated that, as in earlier studies, subordinate monkeys experienced relative deficiencies in luteal phase progesterone activity. In turn, premenopausal monkeys with a high frequency of endocrinologically abnormal menstrual cycles develop significantly more coronary artery atherosclerosis than do monkeys with relatively normal ovarian endocrine function and as much coronary artery atherosclerosis as surgically ovariectomized animals.11 Hence, impaired ovarian function may have contributed to the atherosclerosis of untreated subordinate animals in the present study.
Consistent with the results of the present report, numerous studies of women have shown that emotional distress can result in ovarian dysfunction.33 34 35 36 37 38 39 40 Furthermore, one investigation has linked chronic menstrual irregularity to a significantly increased risk of premature CHD.9 Unfortunately, such data rarely are collected in conjunction with investigations of atherosclerosis and CHD in women. However, independently of such studies, it has been determined that estrogen deficiency associated with secondary amenorrhea is relatively common, affecting between 5% and 18% of women less than 40 years old.5 6 7 8 Up to half the incidence of premature ovarian failure is attributed to undetermined causes, which are often assumed to be of environmental or psychogenic origin (FHA).8 These data provide circumstantial evidence that a substantial subset of premenopausal women may experience prolonged periods of ovarian dysfunction, some of which is due to "stress" but all of which may contribute to atherogenesis. A related observation of potential importance is that, in the studies involving nonhuman primates, relatively modest impairment of ovarian function is associated with substantial exacerbation of atherosclerosis.11 It is reasonable to presume that such moderate ovarian abnormalities, in women, would be occult. If so, the percentage of premenopausal women at risk of accelerated atherosclerosis may be considerably larger than that indicated by the incidence of (diagnosed) FHA.11
It is perhaps worth noting that FHA in women is characterized by hypercortisolemia (presumably induced by stress-related release of corticotropin-releasing factor), further emphasizing the link between psychogenic stress and ovarian impairment.41 Women with FHA also exhibit increased cognitive dysfunction and psychiatric morbidity.42 Taken together, these findings indicate that FHA may be one of the manifestations of a multifaceted stress disorder. Subordinate social status may place female monkeys at high risk for an analogous stress disorder, because such animals tend to be hypercortisolemic10 27 and, as stated previously, often exhibit behavioral withdrawal and other signs of depression26 as well as ovarian impairment. Thus, although there may exist no precise human analogue for subordinate female monkeys, these animals appear to display behavioral and physiological characteristics similar to those observed in at least one subset of women, those with FHA.
In the present study, treatment with an OC resulted in a significant inhibition of atherogenesis. Such inhibition is consistent with the hypothesis that impaired ovarian function potentiated atherogenesis in the stressed subordinates; the outcome also could imply an offsetting beneficial effect of ovarian hormone treatment, regardless of the mechanism responsible for the worsened atherosclerosis of the subordinate monkeys. In the case of women, controversy exists regarding the effects of combination OC use on risk of CHD and atherosclerosis. For example, there is a well-known increase in CHD risk associated with current OC use.43 However, present evidence indicates that this increase in risk is largely confined to users of older, high-dose OC formulations who are also cigarette smokers.43 44 45 46 47 Furthermore, the fact that the increase in risk disappears after cessation of OC use suggests the involvement of a nonatherogenic mechanism, such as thrombosis or vasospasm. More importantly, some studies provide evidence of decreased risk for CHD among OC users,47 and at least one angiographic investigation has shown that OC users have less atherosclerosis than nonusers.48 This latter evidence, together with the results of the present study, suggest that combination OC use may be antiatherogenic. The results of the present study tempt speculation that this effect is manifested largely among those females made vulnerable to atherosclerosis by psychosocial stress or other contributors to ovarian impairment.
The substantial reduction in HDLC associated with combination OC use is often identified as a potential contributor to increased risk of CHD.1 3 The present study provides no evidence that an OC-induced reduction in HDLC, even if large, can offset the antiatherogenic effects of hormone treatment. Although not demonstrated in the present study, considerable evidence is provided by previous research that the estrogenic component of the hormone treatment probably exerts a beneficial effect by acting directly on the artery wall to prevent LDL uptake and maintain normal vasomotor activity.49 50 The finding that the conjoint effects of social status and OC treatment remained even after removal of plasma lipid effects by covariance analysis indicates that both the exacerbation of atherosclerosis among untreated subordinates and the inhibition of lesion development among the rest of the monkeys were independent of variability in plasma lipids.
A potential limiting factor of the current study was the reliance on iliac artery atherosclerosis as a surrogate for atherogenesis in the coronary arteries. However, studies in other animal models (eg, pigeons and rabbits) have relied almost exclusively on noncoronary preparations, whereas the carotid artery is commonly used as a surrogate for the coronary arteries in studies of humans.51 52 Indeed, our preliminary data indicated that in the cynomolgus monkey atherosclerosis in the iliac artery corresponds to that in the coronary arteries at least as well as does atherosclerosis in the carotid artery.
Despite the foregoing limitation, we believe the present study demonstrates clearly that the stress of social subordination exacerbates atherosclerosis in premenopausal monkeys, possibly through a mechanism involving impaired ovarian function. Notably, this exacerbation of atherosclerosis can be inhibited by dominant social status and either inhibited or offset by OC treatment. These results provide additional evidence that estrogen treatment may be antiatherogenic in women. Such evidence is particularly important in the absence of clinical trials investigating the effects of estrogen treatment on atherosclerosis and CHD.53
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
This study was supported in part by grant 1P01-HL-45666, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.
|
Footnotes |
|---|
Reprint requests to Jay R. Kaplan, PhD, Department of Comparative Medicine, Bowman Gray School of Medicine of Wake Forest University, Medical Center Blvd, Winston-Salem, NC 27157-1040. E-mail jkaplan@cpm.bgsm.wfu.edu.
Received April 4, 1995; accepted August 16, 1995.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med. 1991;151:75-78.
2. Lobo RA. Hormones, hormone replacement and heart disease. In: Douglas PS, ed. Cardiovascular Health and Disease in Women. Philadelphia, Pa: WB Saunders Co; 1993:153-173.
3. Clarkson TB, Adams MR, Williams JK, Wagner JD. Clinical implications of animal models of gender difference in heart disease. In: Douglas PS, ed. Cardiovascular Health and Disease in Women. Philadelphia, Pa: WB Saunders Co; 1993:283-302.
4.
Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS,
Wolfe MS, Clarkson TB. Inhibition of coronary artery
atherosclerosis by 17-beta estradiol in ovariectomized
monkeys: lack of an effect of added progesterone.
Arteriosclerosis. 1990;10:1051-1057.
5. Kinch RAH, Plunkett ER, Smout MS, Carr DH. Primary ovarian failure: a clinicopathological and cytogenetic study. Am J Obstet Gynecol. 1965;91:630-644. [Medline] [Order article via Infotrieve]
6. Russell P, Bannatyne P, Shearman RP, Fraser IS, Corbett P. Premature hypergonadotropic ovarian failure: clinicopathological study of 19 cases. Int J Gynecol Pathol. 1982;1:185-201. [Medline] [Order article via Infotrieve]
7. Starup J, Sele V. Premature ovarian failure. Acta Obstet Gynecol Scand. 1973;52:259-268. [Medline] [Order article via Infotrieve]
8. Aiman J, Smentek C. Premature ovarian failure. Obstet Gynecol. 1985;66:9-14. [Medline] [Order article via Infotrieve]
9. LaVecchia C, Decardi A, Franceschi S, Gentile A, Negri E, Parazzini F. Menstrual and reproductive factors and the risk of myocardial infarction in women under fifty-five years of age. Am J Obstet Gynecol. 1987;157:1108-1112. [Medline] [Order article via Infotrieve]
10. Adams MR, Kaplan JR, Koritnik DR. Psychosocial influences on ovarian endocrine and ovulatory function in Macaca fascicularis. Physiol Behav. 1985;35:935-940. [Medline] [Order article via Infotrieve]
11.
Adams MR, Kaplan JR, Koritnik DR, Clarkson TB.
Ovariectomy, social status, and atherosclerosis in
cynomolgus monkeys.
Arteriosclerosis. 1985;5:192-200.
12.
Shively CA, Clarkson TB. Social status and
coronary artery atherosclerosis in female
monkeys. Arterioscler Thromb. 1994;14:721-726.
13. Kaplan JR, Adams MR, Clarkson TB, Koritnik DR. Psychosocial influences on female "protection" among cynomolgus macaques. Atherosclerosis. 1984;53:283-295. [Medline] [Order article via Infotrieve]
14. Kaplan JR, Adams MR, Clarkson TB, Manuck SB, Shively CA. Social behavior and gender in biomedical investigations using monkeys: studies in atherogenesis. Lab Anim Sci. 1991;41:334-343. [Medline] [Order article via Infotrieve]
15.
Kaplan JR, Manuck SB, Clarkson TB, Lusso FM, Taub
DM. Social status, environment, and
atherosclerosis in cynomolgus monkeys.
Arteriosclerosis. 1982;2:359-368.
16. Sade DS. An ethogram for rhesus monkeys, I: antithetical contrasts in posture and movement. Am J Phys Anthropol. 1973;38:537-542. [Medline] [Order article via Infotrieve]
17. Sade DS. Determinants of dominance in a group of free ranging rhesus monkeys. In: Altmann S, ed. Social Communication Among Primates. Chicago, Ill: University of Chicago Press; 1967:99-114.
18. Rush RL, Leon L, Turrell J. Automated simultaneous cholesterol and triglyceride determination on the auto analyzer II instrument. In: Baraton EC, DuCros EJ, Erdrich MM, eds. Advances in Automated Analysis. Mt Kisco, NY: Futura Publishing; 1971:503-507.
19. Lipid Research Clinics Program. Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. Bethesda, Md: National Institutes of Health, 1974. US Dept of Health, Education, and Welfare publication 75-628.
20.
Corbett WT, Schey HM, Lehner NDM, Greene AW.
Standardized method for recording blood pressure in
anesthetized Macaca fascicularis. Lab
Anim. 1981;15:37-40.
21. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950;21:607-611.
22. Kirk RE. Experimental Design: Procedures for the Behavioral Sciences. Belmont, Calif: Brooks/Cole; 1968.
23. McGill HC, Stern NP. Sex and atherosclerosis. Atheroscler Rev. 1979;4:157-242.
24. Fields SK, Savard MA, Epstein KR. The female patient. In: Douglas PS, ed. Cardiovascular Health and Disease in Women. Philadelphia, Pa: WB Saunders Co; 1993:3-21.
25. Haynes SG, Czajkowski SM. Psychosocial and environmental correlates of heart disease. In: Douglas PS, ed. Cardiovascular Health and Disease in Women. Philadelphia, Pa: WB Saunders Co; 1993:269-282.
26. Shively CA, Kaplan JR, Adams MR. Effects of ovariectomy, social instability and social status on female Macaca fascicularis social behavior. Physiol Behav. 1986;36:1147-1153. [Medline] [Order article via Infotrieve]
27. Kaplan JR, Adams MR, Koritnik DR, Rose JC, Manuck SB. Adrenal responsiveness and social status in intact and ovariectomized Macaca fascicularis. Am J Primatol. 1986;11:181-193.
28. Dittus WPJ. The evolution of behaviors regulating density and age-specific sex ratios in a primate population. Behaviour. 1979;69:265-302.
29. Drickamer LC. A ten-year summary of reproductive data for free-ranging Macaca mulatta. Folia Primatol (Basel). 1974;21:61-80. [Medline] [Order article via Infotrieve]
30. Sade DS, Cushing K, Cushing P, Dunaif J, Figueroa A, Kaplan JR, Lauer C, Rhodes D, Schneider J. Population dynamics in relation to social structure on Cayo Santiago. Yearbook Phys Anthropol. 1976;20:253-262.
31. Silk JB, Clark-Wheatley C, Rodman PS, Samuels A. Differential reproductive success and facultative adjustment of sex ratios among captive female bonnet macaques (Macaca radiata). Anim Behav. 1981;29:1106-1120.
32. Wilson ME, Gordon TP, Bernstein IS. Timing of births and reproductive success in rhesus monkey social groups. J Med Primatol. 1978;7:202-212. [Medline] [Order article via Infotrieve]
33. Drew FL. The epidemiology of secondary amenorrhea. J Chron Dis. 1961;14:396-407. [Medline] [Order article via Infotrieve]
34. Strachan GI, Skottowe I. Menstruation and the menopause in mental disease. Lancet. 1933;1:1058-1061.
35.
Whitacre FE, Barrera B. War amenorrhea: a
clinical and laboratory study. JAMA. 1944;124:399-403.
36. Russell GF. Psychological and nutritional factors in disturbances of menstrual function and ovulation. Postgrad Med J. 1972;43:10-13.
37. Fries M, Nillius SJ. Psychological factors, psychiatric illness and amenorrhea after oral contraceptive treatment. Acta Psychiatr Scand. 1973;49:653-668. [Medline] [Order article via Infotrieve]
38. Brown E, Bain J, Lerner P, Shaul L. Psychological, hormonal, and weight disturbances in functional amenorrhea. Can J Psychiatry. 1983;28:624-628. [Medline] [Order article via Infotrieve]
39. Fries H, Nillius SJ, Peterson F. Epidemiology of secondary amenorrhea, II: a retrospective evaluation of etiology with special regard to psychogenic factors and weight loss. Am J Obstet Gynecol. 1974;118:473-479. [Medline] [Order article via Infotrieve]
40. Schreiber C, Florin I, Rost W. Psychological correlates of functional secondary amenorrhea. Psychother Psychosom. 1983;39:106-111. [Medline] [Order article via Infotrieve]
41.
Berga SL, Loucks AB, Rossmanith WG, Kettel LM, Laughlin
GA, Yen SSC. Acceleration of luteinizing hormone pulse frequency
in functional hypothalamic amenorrhea by dopaminergic blockade.
J Clin Endocrinol Metab. 1991;72:151-156.
42. Giles DE, Berga SL. Cognitive and psychiatric correlates of functional hypothalamic amenorrhea: a controlled comparison. Fertil Steril. 1993;60:486-492. [Medline] [Order article via Infotrieve]
43. Mishell DR Jr. Use of oral contraceptives in women of older reproductive age. Am J Obstet Gynecol. 1988;158:1652-1657. [Medline] [Order article via Infotrieve]
44. Realini JP, Goldzieher JW. Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies. Am J Obstet Gynecol. 1985;152:792-798.
45. Thorneycroft IH. Oral contraceptives and myocardial infarction. Am J Obstet Gynecol. 1990;163:1393-1397. [Medline] [Order article via Infotrieve]
46. Thorogood M, Vessey MP. An epidemiologic survey of cardiovascular disease in women taking oral contraceptives. Am J Obstet Gynecol. 1990;163:274-281. [Medline] [Order article via Infotrieve]
47. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. Past use of oral contraceptives and cardiovascular disease: a meta-analysis in the context of the Nurses' Health Study. Am J Obstet Gynecol. 1990;163:285-291. [Medline] [Order article via Infotrieve]
48.
Engel HJ, Engel E, Lichtlen PR. Coronary
atherosclerosis and myocardial infarction in young
women: role of oral contraceptives. Eur Heart J. 1983;4:1-8.
49. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88:1995-2002.
50.
Williams JK, Adams MR, Klopfenstein HS. Estrogen
modulates responses of atherosclerotic coronary
arteries. Circulation. 1990;81:1680-1687.
51.
Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM,
Toole JF, McMahan MR, Thompson CJ, Heiss G, Crouse JR.
Evaluation of the association between carotid artery
atherosclerosis and coronary artery
stenosis. Circulation. 1990;82:1230-1242.
52.
Pettersson K, Bejne B, Bjork H, Strawn WB, Bondjers
G. Experimental sympathetic activation causes
endothelial injury in the rabbit thoracic aorta via
ß1-adrenoceptor activation. Circ
Res. 1990;67:1027-1034.
53. LaRosa JC. Estrogen: risk versus benefit for the prevention of coronary artery disease. Coron Artery Dis. 1993;4:588-594.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  C. L. Shufelt and C. N. Bairey Merz Contraceptive hormone use and cardiovascular disease. J. Am. Coll. Cardiol., January 20, 2009; 53(3): 221 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Snell-Bergeon, D. Dabelea, L. G. Ogden, J. E. Hokanson, G. L. Kinney, J. Ehrlich, and M. Rewers Reproductive History and Hormonal Birth Control Use Are Associated with Coronary Calcium Progression in Women with Type 1 Diabetes Mellitus J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2142 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Register, J. A. Cann, J. R. Kaplan, J. K. Williams, M. R. Adams, T. M. Morgan, M. S. Anthony, R. M. Blair, J. D. Wagner, and T. B. Clarkson Effects of Soy Isoflavones and Conjugated Equine Estrogens on Inflammatory Markers in Atherosclerotic, Ovariectomized Monkeys J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1734 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Morimoto, Y. Kurahashi, K. Shintani-Ishida, N. Kawamura, M. Miyashita, M. Uji, N. Tan, and K.-i. Yoshida Estrogen replacement suppresses stress-induced cardiovascular responses in ovariectomized rats Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1950 - H1956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Kalantaridou, K. K. Naka, E. Papanikolaou, N. Kazakos, M. Kravariti, K. A. Calis, E. A. Paraskevaidis, D. A. Sideris, A. Tsatsoulis, G. P. Chrousos, et al. Impaired Endothelial Function in Young Women with Premature Ovarian Failure: Normalization with Hormone Therapy J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3907 - 3913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Wood, J. M. Cline, M. S. Anthony, T. C. Register, and J. R. Kaplan Adrenocortical Effects of Oral Estrogens and Soy Isoflavones in Female Monkeys J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2319 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Register, M. J. Jayo, and M. S. Anthony Soy Phytoestrogens Do Not Prevent Bone Loss in Postmenopausal Monkeys J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4362 - 4370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Alexandersen, J. Haarbo, P. Zandberg, J. Jespersen, S. O. Skouby, and C. Christiansen Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study Hum. Reprod., July 1, 2003; 18(7): 1395 - 1403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Noel Bairey Merz, B. D. Johnson, B. L. Sharaf, V. Bittner, S. L. Berga, G. D. Braunstein, T. K. Hodgson, K. A. Matthews, C. J. Pepine, S. E. Reis, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study J. Am. Coll. Cardiol., February 5, 2003; 41(3): 413 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Clarkson, M. S. Anthony, and T. M. Morgan Inhibition of Postmenopausal Atherosclerosis Progression: A Comparison of the Effects of Conjugated Equine Estrogens and Soy Phytoestrogens J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 41 - 47. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Holvoet, G. Theilmeier, B. Shivalkar, W. Flameng, and D. Collen LDL Hypercholesterolemia Is Associated With Accumulation of Oxidized LDL, Atherosclerotic Plaque Growth, and Compensatory Vessel Enlargement in Coronary Arteries of Miniature Pigs Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 415 - 422. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||